RESMED INC — Director's Dealing 2016

Jan 5, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-01-04

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-04	ResMed Common Stock	S	500	$52.97	Disposed	75611.3415	Indirect
2016-01-04	ResMed Common Stock	M	5837	$19.25	Acquired	81448.3415	Indirect
2016-01-04	ResMed Common Stock	S	5837	$52.97	Disposed	75611.342	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-04	ResMed Common Stock Options	$19.25	M	5837	Disposed	2016-02-03	ResMed Common Stock (5837)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	31304	Direct

Footnotes

F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable.